These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26381413)

  • 1. Current and Emerging Drug Targets for Human Immunodeficiency Virus.
    Waheed AA; Tachedjian G
    Curr Top Med Chem; 2016; 16(10):1072-3. PubMed ID: 26381413
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting strategies for Human immunodeficiency virus: a combinatorial approach.
    Saxena SK; Gupta A; Bhagyashree K; Saxena R; Arora N; Banerjee AK; Tripathi AK; Chandrasekar MJ; Gandhi N; Nair MP
    Mini Rev Med Chem; 2012 Mar; 12(3):236-54. PubMed ID: 22356194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picture story. Keeping HIV out.
    Konforti B
    Nat Struct Biol; 1999 Nov; 6(11):1004. PubMed ID: 10542088
    [No Abstract]   [Full Text] [Related]  

  • 4. The world of HIV and disease, and some new approaches to block it.
    Gallo R
    Bull Mem Acad R Med Belg; 1998; 153(7-9):339-42. PubMed ID: 10100397
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection.
    Lederman MM; Jump R; Pilch-Cooper HA; Root M; Sieg SF
    Retrovirology; 2008 Dec; 5():116. PubMed ID: 19094217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drug makes host cell machinery unavailable to HIV.
    Senior K
    Mol Med Today; 1999 Jun; 5(6):234-5. PubMed ID: 10366815
    [No Abstract]   [Full Text] [Related]  

  • 7. [AIDS drug in the correct form].
    Schenk M
    Dtsch Med Wochenschr; 1998 Sep; 123(36):A9. PubMed ID: 9765604
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapeutic interventions targeting HIV interactions with host-associated carbohydrates.
    McReynolds KD; Gervay-Hague J
    Chem Rev; 2007 May; 107(5):1533-52. PubMed ID: 17439183
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in anti-HIV chemotherapy.
    De Clercq E
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):258-75. PubMed ID: 12084468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for persistent HIV.
    Keedy KS; Margolis DM
    Trends Pharmacol Sci; 2010 May; 31(5):206-11. PubMed ID: 20207023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In search of a treatment for HIV--current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs).
    Reynolds C; de Koning CB; Pelly SC; van Otterlo WA; Bode ML
    Chem Soc Rev; 2012 Jul; 41(13):4657-70. PubMed ID: 22618809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting the HIV-chemokine nexus.
    Cohen J
    Science; 1997 Feb; 275(5304):1261-4. PubMed ID: 9064780
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting HIV attachment and entry for therapy.
    Strizki J
    Adv Pharmacol; 2008; 56():93-120. PubMed ID: 18086410
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of HIV by chemokine receptor antagonists: exciting new targets, complex development.
    Henson GW
    Expert Rev Anti Infect Ther; 2003 Oct; 1(3):347-9. PubMed ID: 15482129
    [No Abstract]   [Full Text] [Related]  

  • 15. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoresistance: an emerging clinical problem.
    Carosi G
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):9-14. PubMed ID: 9689572
    [No Abstract]   [Full Text] [Related]  

  • 17. Chasing HIV from its hiding place.
    Erdmann J
    Chem Biol; 2010 Aug; 17(8):787-8. PubMed ID: 20797604
    [No Abstract]   [Full Text] [Related]  

  • 18. Setback prompts rethink of latency-reversing strategy to eliminate HIV infection.
    Katsnelson A
    Nat Rev Drug Discov; 2014 Jun; 13(6):403-4. PubMed ID: 24875082
    [No Abstract]   [Full Text] [Related]  

  • 19. What's new in HIV.
    Morris-Jones S; Nelson MR
    J Infect; 1999 Mar; 38(2):i-ii. PubMed ID: 10342641
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and anti-human immunodeficiency virus activity of the skeleton isomers of 3',4'-Di-(O)-(-)-camphanoyl-(+)-khellactone.
    Nishioka H; Uesugi K; Ueda N; Kondo Y; Tsuji M; Abe H; Harayama T; Hamasaki T; Baba M; Takeuchi Y
    Chem Pharm Bull (Tokyo); 2011; 59(8):1075-6. PubMed ID: 21804260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.